Thermo Fisher Introduces High-Throughput PCR to Expand Covid-19 Response
The highly automated, real-time PCR solution can analyze up to 6,000 samples per day to help meet demand for covid-19 testing.
Read MorePosted by Melanie Hamilton-Basich | Aug 8, 2020 | Covid 19, Molecular Diagnostics |
The highly automated, real-time PCR solution can analyze up to 6,000 samples per day to help meet demand for covid-19 testing.
Read MorePosted by Melanie Hamilton-Basich | Aug 8, 2020 | Covid 19, Immunoassay Reagents & test Kits, Molecular Diagnostics |
Kits include two real-time RT-PCR test kits for detecting nucleic acid from SARS-CoV-2 and test kits for detecting antibodies to SARS-CoV-2.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Company News, Covid 19, Immunoassay Reagents & test Kits |
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Covid 19, Uncategorized |
Elevated levels of these five biomarkers were associated with inflammation and bleeding disorder as well as increased risk of death in covid-19 patients.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Covid 19, Uncategorized |
Seven governors are working together to secure a deal for SARS-CoV-2 antigen tests in a bid to create the country’s first coordinated testing strategy.
Read More